From January 1, 2024 to March 31, 2024, the company has repurchased 310,912 shares, representing 0.23% for CNY 14.91 million. With this, the company has completed the repurchase of 607,326 shares, representing 0.45% for CNY 34.9 million under the buyback announced on November 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.9 CNY | -1.64% | -8.00% | -51.89% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.89% | 612M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.51% | 22.1B | |
-8.33% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- 688202 Stock
- News Shanghai Medicilon Inc.
- Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.